Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
TV & Film
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/24/ac/f4/24acf4b0-38c7-ff90-fbdc-5fd01805d888/mza_12329112008560979196.jpg/600x600bb.jpg
Pharmacy Insights Podcast
Optum Rx
14 episodes
2 weeks ago
Introducing the Pharmacy Insights Podcast from Optum Rx. This ongoing series features our most experienced leaders examining the topics currently challenging pharmacy benefit plan sponsors. Join Optum Rx Senior Vice President of Clinical Consulting Scott Draeger as he interviews leading experts to uncover the emerging solutions needed to control rising prescription drug costs and ensure the best possible quality of care.
Show more...
Business
RSS
All content for Pharmacy Insights Podcast is the property of Optum Rx and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Introducing the Pharmacy Insights Podcast from Optum Rx. This ongoing series features our most experienced leaders examining the topics currently challenging pharmacy benefit plan sponsors. Join Optum Rx Senior Vice President of Clinical Consulting Scott Draeger as he interviews leading experts to uncover the emerging solutions needed to control rising prescription drug costs and ensure the best possible quality of care.
Show more...
Business
https://is1-ssl.mzstatic.com/image/thumb/Podcasts126/v4/24/ac/f4/24acf4b0-38c7-ff90-fbdc-5fd01805d888/mza_12329112008560979196.jpg/600x600bb.jpg
What you can and can’t expect from biosimilars.
Pharmacy Insights Podcast
12 minutes 34 seconds
3 years ago
What you can and can’t expect from biosimilars.
Guest: Sr. Vice President, Optum Rx Clinical and Formulary Services, Savitha Vivian. Long established in Europe, biosimilar alternatives to popular and costly biologic drugs are finally poised to make an impact in the U.S. With biosimilar alternatives to Humira now launching, what does that mean for prescription drug spending?
Pharmacy Insights Podcast
Introducing the Pharmacy Insights Podcast from Optum Rx. This ongoing series features our most experienced leaders examining the topics currently challenging pharmacy benefit plan sponsors. Join Optum Rx Senior Vice President of Clinical Consulting Scott Draeger as he interviews leading experts to uncover the emerging solutions needed to control rising prescription drug costs and ensure the best possible quality of care.